Two Sigma Investments
BIOL

Two Sigma Investments’s Biolase, Inc. BIOL Stock Holding History

Two Sigma Investments’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,726
Closed -$12K – 3473
2023
Q4 		$12K Buy
+10,726
New +$15.3K ﹤0.01% 3076
2021
Q4 		– Sell
-77
Closed -$123K – 5033
2021
Q3 		$123K Buy
77
+33
+75% +$53.9K ﹤0.01% 4057
2021
Q2 		$76K Buy
+44
New +$81.7K ﹤0.01% 3929

Other funds holding BIOL

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KWA
Kellett Wealth Advisors Cincinnati, Ohio $215M AUM 22.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Two Sigma Investments's BIOL Position: Q1 2024 in Review

Two Sigma Investments sold out of Biolase, Inc. (BIOL) in Q1 2024, closing a stake of 10,726 shares — an estimated $12K sold.

Two Sigma Investments first reported a position in BIOL in Q2 2021 and held it in 3 quarters. The position peaked at $123K in Q3 2021. 18 funds tracked by Wall St. Rank hold BIOL as of Q1 2024.

  • Two Sigma Investments reported no remaining Biolase, Inc. position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 10,726 Biolase, Inc. shares in Q1 2024, an estimated $12K.
  • Two Sigma Investments first reported a position in Biolase, Inc. in Q2 2021 and held it in 3 quarters.
  • Two Sigma Investments's Biolase, Inc. position peaked at $123K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.